Literature DB >> 29721855

Id1 and Sonic Hedgehog Mediate Cell Cycle Reentry and Apoptosis Induced by Amyloid Beta-Peptide in Post-mitotic Cortical Neurons.

A-Ching Chao1,2, Chien-Hui Chen3, Shih-Hsin Chang3, Chao-Tzu Huang3, Wei-Chao Hwang4, Ding-I Yang5.   

Abstract

Amyloid beta-peptide (Aβ), the neurotoxic component of senile plaques in Alzheimer's disease (AD) brains, is known to trigger cell cycle reentry in post-mitotic neurons followed by apoptosis. However, the underlying mechanisms remain unclear. Recently, we have reported that Aβs stimulate the expression of inhibitor of differentiation-1 (Id1) to induce sonic hedgehog (SHH) (Hung et al., Mol Neurobiol 53(2):793-809, 2016), and both are mitogens capable of triggering cell cycle progression. In this work, we tested the hypothesis that Aβ-induced Id1 and SHH contribute to cell cycle reentry leading to apoptosis in neurons. We found that Aβ triggered cell cycle progression in the post-mitotic neurons, as indicated by the increased expression of two G1-phase markers including cyclin D1 and phosphorylated retinoblastoma protein (pRb), two G2-phase markers such as proliferating cell nuclear antigen (PCNA) and incorporation of 5-bromo-2'-deoxyuridine (BrdU) into newly synthesized DNA, as well as the mitotic marker histone H3 phosphorylated at Ser-10. As expected, Aβ also enhanced caspase-3 cleavage in the cortical neurons. Id1 siRNA, the neutralization antibody against SHH (SHH-Ab), and the cyclin-dependent kinase (CDK)-4/6 inhibitor PD0332991 all attenuated, in part or in full, the Aβ-induced expression of these cell cycle markers. Indeed, exogenous recombinant Id1 protein and the biologically active N-terminal fragment of SHH (SHH-N) were both sufficient to enhance the expression of cell cycle markers independent of Aβ. Taken together, our results revealed the critical roles of Id1 and SHH mediating Aβ-dependent cell cycle reentry and subsequently caspase-dependent apoptosis in the fully differentiated post-mitotic neurons, at least in vitro.

Entities:  

Keywords:  Alzheimer’s disease (AD); Caspase-3; Cyclin D1; Histone H3; Proliferating cell nuclear antigen (PCNA); Retinoblastoma protein (pRb)

Mesh:

Substances:

Year:  2018        PMID: 29721855     DOI: 10.1007/s12035-018-1098-5

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  4 in total

Review 1.  Applications and mechanisms of the cyclin-dependent kinase 4/6 inhibitor, PD-0332991, in solid tumors.

Authors:  Wenjian Chen; Wencheng Zhang; Miaomiao Chen; Chao Yang; Ting Fang; Haifeng Wang; Lola M Reid; Zhiying He
Journal:  Cell Oncol (Dordr)       Date:  2022-09-10       Impact factor: 7.051

Review 2.  Emerging Roles of Inhibitor of Differentiation-1 in Alzheimer's Disease: Cell Cycle Reentry and Beyond.

Authors:  Shang-Der Chen; Jenq-Lin Yang; Yi-Chun Lin; A-Ching Chao; Ding-I Yang
Journal:  Cells       Date:  2020-07-21       Impact factor: 6.600

Review 3.  Nuclear dynamics and stress responses in Alzheimer's disease.

Authors:  Artemis Iatrou; Eric M Clark; Yanling Wang
Journal:  Mol Neurodegener       Date:  2021-09-17       Impact factor: 14.195

4.  Baicalin Attenuated Aβ 1-42-Induced Apoptosis in SH-SY5Y Cells by Inhibiting the Ras-ERK Signaling Pathway.

Authors:  Zhenyan Song; Chunxiang He; Wenjing Yu; Miao Yang; Ze Li; Ping Li; Xu Zhu; Chen Xiao; Shaowu Cheng
Journal:  Biomed Res Int       Date:  2022-04-27       Impact factor: 3.246

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.